In conclusion, this study demonstrates for the first time that AD could inhibit TNBC cell growth both in vitro and in vivo, and the mechanism of these effects was associated or at least partially associated with the inhibition of the Akt/mTOR and STAT3 signaling pathways. The gene discussed is STAT3; the disease is Alzheimer disease.